Richardson Financial Services Inc. Sells 251 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Richardson Financial Services Inc. decreased its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 18.4% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,110 shares of the company’s stock after selling 251 shares during the period. Richardson Financial Services Inc.’s holdings in HCA Healthcare were worth $357,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Independent Advisor Alliance increased its stake in shares of HCA Healthcare by 8.2% in the 4th quarter. Independent Advisor Alliance now owns 948 shares of the company’s stock valued at $257,000 after buying an additional 72 shares during the period. Gladstone Institutional Advisory LLC acquired a new position in HCA Healthcare during the 4th quarter valued at about $200,000. Corient Private Wealth LLC grew its position in shares of HCA Healthcare by 22.8% during the 4th quarter. Corient Private Wealth LLC now owns 43,140 shares of the company’s stock worth $11,677,000 after buying an additional 8,005 shares during the period. Assetmark Inc. lifted its holdings in HCA Healthcare by 27.6% in the fourth quarter. Assetmark Inc. now owns 1,495 shares of the company’s stock valued at $405,000 after buying an additional 323 shares during the period. Finally, InterOcean Capital Group LLC grew its holdings in HCA Healthcare by 4.0% during the 4th quarter. InterOcean Capital Group LLC now owns 3,339 shares of the company’s stock worth $904,000 after acquiring an additional 128 shares during the period. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insiders Place Their Bets

In related news, SVP Kathryn A. Torres sold 1,857 shares of the business’s stock in a transaction that occurred on Thursday, July 25th. The stock was sold at an average price of $355.05, for a total transaction of $659,327.85. Following the transaction, the senior vice president now directly owns 17,755 shares of the company’s stock, valued at approximately $6,303,912.75. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, SVP Kathleen M. Whalen sold 2,987 shares of HCA Healthcare stock in a transaction that occurred on Wednesday, July 31st. The stock was sold at an average price of $363.51, for a total transaction of $1,085,804.37. Following the completion of the sale, the senior vice president now directly owns 9,454 shares of the company’s stock, valued at approximately $3,436,623.54. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, SVP Kathryn A. Torres sold 1,857 shares of the stock in a transaction on Thursday, July 25th. The stock was sold at an average price of $355.05, for a total value of $659,327.85. Following the transaction, the senior vice president now owns 17,755 shares in the company, valued at approximately $6,303,912.75. The disclosure for this sale can be found here. Insiders have sold a total of 17,202 shares of company stock valued at $6,407,273 over the last 90 days. 1.60% of the stock is currently owned by insiders.

HCA Healthcare Trading Up 0.6 %

Shares of NYSE:HCA opened at $399.89 on Thursday. The stock has a market capitalization of $104.74 billion, a PE ratio of 19.93, a price-to-earnings-growth ratio of 1.46 and a beta of 1.67. The company’s 50-day moving average price is $367.24 and its two-hundred day moving average price is $339.56. The company has a debt-to-equity ratio of 27.11, a current ratio of 1.06 and a quick ratio of 0.94. HCA Healthcare, Inc. has a one year low of $215.96 and a one year high of $404.90.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share for the quarter, beating analysts’ consensus estimates of $4.97 by $0.53. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The firm had revenue of $17.49 billion during the quarter, compared to the consensus estimate of $17.05 billion. During the same period last year, the company earned $4.29 earnings per share. The business’s revenue was up 10.3% compared to the same quarter last year. On average, equities analysts forecast that HCA Healthcare, Inc. will post 22.46 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, September 30th. Stockholders of record on Monday, September 16th will be issued a $0.66 dividend. The ex-dividend date is Monday, September 16th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.66%. HCA Healthcare’s payout ratio is 13.16%.

Analyst Ratings Changes

A number of equities research analysts recently commented on HCA shares. Royal Bank of Canada lifted their price objective on HCA Healthcare from $378.00 to $405.00 and gave the stock an “outperform” rating in a research note on Friday, August 23rd. Wolfe Research upgraded shares of HCA Healthcare to a “strong-buy” rating in a research report on Thursday, August 29th. Wells Fargo & Company upped their target price on shares of HCA Healthcare from $315.00 to $365.00 and gave the company an “equal weight” rating in a research note on Tuesday, July 30th. JPMorgan Chase & Co. boosted their price target on shares of HCA Healthcare from $327.00 to $332.00 and gave the company a “neutral” rating in a report on Thursday, May 30th. Finally, Leerink Partners lifted their target price on HCA Healthcare from $367.00 to $396.00 and gave the stock an “outperform” rating in a report on Wednesday, July 24th. Five research analysts have rated the stock with a hold rating, fourteen have given a buy rating and three have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, HCA Healthcare currently has an average rating of “Moderate Buy” and a consensus price target of $359.89.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.